Corline Biomedical AB (STO:CLBIO)
Sweden flag Sweden · Delayed Price · Currency is SEK
13.75
+0.05 (0.36%)
Oct 13, 2026, 10:39 AM CET

Corline Biomedical AB Ratios and Metrics

Millions SEK. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
359352189320198314
Market Cap Growth
-22.78%86.79%-41.07%61.60%-36.85%25.86%
Enterprise Value
331347181303169271
Last Close Price
13.7016.408.7814.909.2214.60

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
----85.08-
Forward PE
-38.9213.413.90108.00108.00
PS Ratio
28.9046.0719.309.028.4144.43
PB Ratio
3.623.762.173.432.103.40
P/TBV Ratio
3.623.762.173.432.103.40
P/FCF Ratio
---424.69--
P/OCF Ratio
---361.41--

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
26.6445.3118.558.547.1938.35
EV/EBITDA Ratio
----71.03-
EV/EBIT Ratio
----72.74-
EV/FCF Ratio
---402.14--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.050.040.02---
Net Debt / Equity Ratio
-0.28-0.18-0.18-0.18-0.28-0.45
Net Debt / EBITDA Ratio
2.281.141.168.09-10.996.05
Net Debt / FCF Ratio
1.890.941.81-22.563.978.37
Asset Turnover
0.120.080.100.350.230.09
Quick Ratio
6.124.742.593.284.824.71
Current Ratio
6.494.982.683.515.004.75
Return on Equity (ROE)
-13.72%-16.29%-25.74%-1.93%2.49%-9.60%
Return on Assets (ROA)
-7.74%-9.56%-8.72%-1.36%1.43%-5.40%
Return on Capital Employed (ROCE)
-11.50%-15.80%-15.60%-2.40%2.50%-7.50%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-3.44%-4.17%-12.29%-0.56%1.18%-2.21%
FCF Yield
-4.14%-5.03%-4.58%0.24%-3.33%-1.59%
Buyback Yield / Dilution
-9.08%-13.40%-1.49%2.19%-7.50%-22.58%